Research Article
Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis
Table 4
Univariate analysis of factors related to prognosis in patients within follow-up (
).
| | Factors | Death
() | Survival
() | Mann–Whitney test ()/Pearson test ()/Kruskal-Wallis test () | value |
| | Gender (male/female) | 17/2 | 25/3 | −0.000 | 1.000 | | Age (year) | 46 25 | 50.5 ± 13.75 | −0.651 | 0.515 | | AFP (ng/ml) | 528.8 ± 3064.72 | 93.62 ± 1153.70 | −0.902 | 0.367 | | ALT (IU/L) | 37 ± 23.5 | 46 ± 28 | −1.206 | 0.228 | | HBeAg (positive/negative) | 2/17 | 8/20 | 2.201 | 0.168 | | HBVDNA (IU/mL) | 500 ± 0 | 500 ± 10775 | −1.192 | 0.233 | | Ishak Score | 4 ± 2 | 5 ± 2 | −0.906 | 0.365 | | Tumor Size (5 cm/⩾5 cm) | 5/14 | 11/17 | 0.848 | 0.357 | | Differentiated degree (poor/moderate/high) | 3/16/0 | 3/20/5 | 3.863 | 0.145 | | Capsule invasion (positive/negative) | 9/10 | 15/13 | 0.174 | 0.676 | | Margin involvement (positive/negative) | 2/17 | 1/27 | 0.916 | 0.338 | | Tumor thrombus (positive/negative) | 10/9 | 3/25 | 9.940 | 0.003 | | Metastasis (positive/negative) | 3/16 | 1/27 | 2.170 | 0.289 | | Axiotis score of ERp57 expression in tissue sections | 10.6 ± 4.15 | 8.025 ± 3.4 | −2.083 | 0.037 |
|
|
